Please login to the form below

Not currently logged in

Pfizer announces commitment to achieve Net-Zero Standard by 2040

The company hopes to achieve the net-zero target ten years earlier than the expectations of the Net-Zero Standard


Pfizer has announced its commitment to further reduce its Greenhouse Gas (GHG) emissions, aiming to achieve a voluntary net-zero target by 2040, ten years earlier than the expectations of the Net-Zero Standard.

The Net-Zero Standard urges long-term action to reduce company emissions by 95% and value chain emissions by 90%.

To meet this commitment, Pfizer will need to move away from the use of fossil fuels at an accelerated rate, which will include the use of a fleet of hybrid and electric vehicles, and will encourage suppliers to take similar action.

The company is working with suppliers to encourage a commitment to climate change that includes establishing a GHG baseline by the end of 2022 and setting a reduction target by the end of 2025.

The company has also signed a pledge by the US Department of Health and Human Services (HHS) that calls on stakeholders in the US healthcare system – including hospitals, health systems, payers, suppliers and pharmaceutical companies – to reduce GHG emissions and ‘build a more climate resilient healthcare infrastructure’. As part of the commitment, Pfizer will publicly report on its progress.

Commenting on the commitment, Pfizer chairman and chief executive officer Albert Bourla, said: "The window is closing to minimise the potentially catastrophic impact of climate change, which affects the health of our planet and that of people around the world.

“With urgency of action increasing, we firmly believe that our commitment to accelerate decarbonisation of our value chain and achieve the Net-Zero standard can help drive positive change and build a healthier, more sustainable world.”

Between 2000 and 2020, the company reduced company emissions by over 60%.

In 2020, Pfizer announced a plan to become carbon neutral by 2030 and to reduce Scope 1 & 2 GHG emissions by 46% from a 2019 baseline. Scope 1 emissions occur from sources controlled or owned by an organisation, Scope 2 are associated with the purchase of electricity, steam, heat or cooling.

The company has outlined that it remains committed to these 2030 goals as ‘an interim milestone’ toward its new Net-Zero 2040 goal.

Article by
Emily Kimber

4th July 2022

From: Healthcare



Subscribe to our email news alerts


Add my company

We are a leading provider of outsourced commercial, medical and recruitment services to UK pharmaceutical, biotech and healthcare companies....

Latest intelligence

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
New Playbook Alert: Virtual Patient Engagement
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...